The company's device, BioPrax, is currently being investigated for its ability to eliminate biofilm infections on prosthetic knee implants during early intervention procedures, while maintaining the current standard of care. Garwood's patented technologies provide electrical stimulation treatments for peri-prosthetic infection, including antibiotic-resistant bacteria, and their core mission is to advance infection control through innovation.